Discover why 23andMe is the best DNA test for people with African ancestry

23andMe offers the most detailed view of African ancestry, connecting you to hundreds of ethnic groups in Africa, plus ancient maternal and paternal lineages. You can also get personalized health insights, all with full control over your data.

Two women smiling with a 23andMe DNA kit

Most comprehensive ancestry detail

23andMe offers the most comprehensive African ancestry detail of any DNA testing company, connecting users to over 260 African ethnic groups, including Yoruba, Igbo, Kongo, and Zulu peoples, plus more than 200 groups in the African diaspora like the Gullah and Garifuna.

Trace ancient African lineages

With haplogroups, you can see where your ancient maternal and paternal lineages originated long ago and learn about the people and places they connect you to. Via analysis of mitochondrial and Y-chromosome DNA.

Optional health reports including Sickle Cell

Access 110+ health reports, including reports on conditions that disproportionately affect people with African ancestry such as sickle cell anemia, high blood pressure, preeclampsia, prostate cancer, type 2 diabetes, and more.

Ancestry reports and features

23andMe, now a research non-profit, has the largest community of research participants with African ancestry in the world, and we have been committed to increasing representation in our cohort through efforts like the African Genetics Project, the Global Genetics Project, the African American Genetics Program and more. That focus on diversity has unlocked key discoveries through research and enabled our team to provide more ancestry detail in Africa than any other DNA testing company.

With more than 260 African ethnic groups we assign matches to you with statistical confidence.

Read our press release →
Map showing 260+ African ethnic groups

Plus, more than 200 African American Genetic Groups in the United States.

Learn more →
Map showing 200+ African American genetic groups in the United States

Real stories from real customers

Industry-leading DNA test with FDA cleared HEALTH REPORTS

Learn more about our FDA authorizations →

Health reports on conditions that disproportionately impact the Black/African American community

23andMe offers many reports about how your DNA may impact your health and wellness. This page highlights reports on conditions that disproportionately affect Black/African American individuals and people of African descent.

Sickle Cell Anemia report example showing 1 variant detected
Type 2 Diabetes report example

Sickle Cell Anemia is a genetic condition that can cause anemia, pain crises, and frequent infections. It occurs when a person inherits two copies of a genetic variant called HbS.

About 1 in 13 African Americans is a carrier for sickle cell anemia (sometimes called having sickle cell trait).

Learn more →

Beta Thalassemia and Related Hemoglobinopathies are genetic conditions that can cause anemia, fatigue, and bone and organ problems. These conditions occur when a person inherits two variants in the HBB gene.

At least 1 in 50 African Americans is a carrier for beta thalassemia or a related blood disorder.

Learn more →

G6PD Deficiency is a common genetic condition that can lead to episodes of anemia, fatigue, and jaundice when certain environmental triggers cause red blood cells to break down.

About 1 in 10 African American men have G6PD deficiency. (Because of how it's inherited, the condition is more common in males than females.)

Learn more →

White Blood Cell Count (Duffy Antigen-Related) tests for a genetic variant that can lead to naturally lower white blood cell (WBC) counts.

Nearly 70% of Black and African Americans have two copies of this variant, a trait called Duffy null status. For these individuals, knowing their Duffy status can help explain why their WBC counts might be lower than most reference ranges — even when they're perfectly healthy — so their doctor doesn't mistake it for a sign of illness.

Learn more →

Hereditary Amyloidosis (TTR-Related) is a genetic condition in which a protein called TTR builds up in organs and tissues like the heart and nerves, causing damage over time.

About 3-4% of African Americans have a specific TTR variant called V122I, which can increase the risk for cardiomyopathy (heart damage).

Learn more →

Coronary Artery Disease occurs when plaque builds up in the arteries that supply the heart with oxygen-rich blood, narrowing the arteries and reducing blood flow.

In the U.S., Black and African Americans face a higher risk of coronary artery disease, tend to develop it earlier, and are more likely to die from heart disease than white Americans.

Learn more →

High Blood Pressure , also called hypertension, is when the blood puts too much pressure on the walls of blood vessels, which can lead to heart disease, stroke, and other health problems.

Black and African Americans are more likely to have high blood pressure than people of other ancestries.

Learn more →

Type 2 Diabetes is a condition where sugar builds up in the blood, which can lead to complications like heart disease and stroke.

About 40% of people in the U.S. are expected to develop type 2 diabetes during their lifetime, but Black and African American individuals have a higher risk.

Learn more →

Chronic Kidney Disease (APOL1-Related) occurs when the kidneys stop working properly over time, causing fluid and waste to build up in the body. This can lead to complications such as heart disease, stroke, and bone problems.

About 13% of African Americans have two variants in the APOL1 gene, which increases their risk for chronic kidney disease. These variants help explain why African Americans are three times as likely to develop kidney failure compared to white Americans.

Learn more →

Breast Cancer is one of the most common types of cancer, impacting about 1 in 8 women during their lifetime.

In the U.S., Black women are 40% more likely to die from breast cancer than white women. They're also more likely to develop triple-negative breast cancer, which is more aggressive, more difficult to treat, and tends to develop at earlier ages.

Learn more →

BRCA1/BRCA2 variants are associated with an increased risk for breast, ovarian, prostate, and pancreatic cancer.

Black and African Americans are less likely to receive BRCA1/2 genetic testing than white Americans. The variants in the 23andMe BRCA1/BRCA2 (Selected Variants) report account for about 30-40% of cancer-related BRCA1 and BRCA2 variants in African Americans.

Learn more →

Prostate Cancer is one of the most common types of cancer, impacting about 1 in 8 men during their lifetime.

In the U.S., Black and African American men are more likely to develop prostate cancer, be diagnosed at younger ages, face more aggressive disease, and experience delays in treatment. They’re also twice as likely to die from prostate cancer compared to men of other ancestries.

Learn more →

Gestational Diabetes is a form of diabetes that starts during pregnancy.

Black and African Americans are at least 1.5 times more likely to progress from gestational diabetes to type 2 diabetes.

Learn more →

Uterine Fibroids are a relatively common type of non-cancerous growth in the uterus that can cause heavy menstrual bleeding, pelvic pressure, and pain.

Black and African Americans have a higher chance of developing uterine fibroids, and they tend to experience an earlier onset and more severe symptoms.

Learn more →

Preeclampsia is a pregnancy-related condition characterized by high blood pressure that can sometimes lead to organ damage.

Preeclampsia affects about 4% of pregnancies in the U.S. Black and African Americans have an increased risk of developing the condition and are three times more likely to die from it.

Learn more →

Alzheimer’s Disease causes memory loss, cognitive decline, and personality changes, with the most common form (called late-onset) developing after age 65.

About 1 in 10 Americans over 65 has Alzheimer’s disease. African American and Hispanic individuals develop late-onset Alzheimer’s disease at higher rates than people of European or Asian descent.

Learn more →

Parkinson’s Disease causes tremor, muscle stiffness, and movement difficulties.

About 1–2% of people will develop Parkinson’s during their lifetime, and Black and African American people are often diagnosed at a later stage than white people. 23andMe is participating in efforts to identify Parkinson’s risk variants for people with African ancestry.

Learn more →

Lupus is an autoimmune condition that can impact many organs in the body.

In the U.S., lupus is more common, often more severe, and tends to appear at younger ages in Black and African Americans.

Learn more →

Asthma is a chronic lung condition that causes wheezing, shortness of breath, and coughing, often triggered by specific environmental or health factors.

African Americans, Puerto Ricans, and Indigenous Americans are more likely to experience asthma.

Learn more →

Glaucoma is an eye condition in which high eye pressure damages the optic nerve, leading to gradual vision loss over time.

In the U.S., Black and African Americans are about five times more likely to develop glaucoma, six times more likely to go blind from it, and develop it about 10 years earlier than people of other ancestries.

Learn more →

Note that our health reports have limitations

Our reports don't test for every possible genetic variant linked to each condition, due to limitations of our genotyping technology. Because some variants are more common in certain populations, we may miss variants relevant to your ancestry.

For reports powered by 23andMe research, like our Colorectal Cancer PRS report, we sometimes lack sufficient data to create a genetic prediction that meets our scientific standards for all ancestries. This means results may not be available for some people.

We aim to be transparent, and we are continually working to improve and expand our offerings to better serve all communities.

It's also important to acknowledge that social determinants of health are major contributors to health disparities for Black and African Americans and other communities. We believe learning about genetic risk can empower action. But combining it with efforts to address these social challenges is essential for a healthier future.

You are in control of your data

It's your data, so you call the shots. From the moment you register your kit and set up your private account, you have meaningful choice in everything you do. That means you decide how your information is used and whether it is shared. You are free to change your mind at any time. You can download your data, delete your account or have us discard your sample in your account settings at any point.

Learn more about our privacy and security practices →

Advancing research equity and health outcomes

23andMe is proactively building a more diverse community of researchers and participants to improve research equity and health outcomes for Black/African Americans.

Community Impact Programs

Recent initiatives focused on health conditions that disproportionately impact the Black/African American community, in partnership with organizations rooted and engaged in the community.

This initiative aims to help people learn their sickle cell trait (SCT) status, promote sickle cell disease (SCD) awareness, and offer resources to those with SCD and SCT, by partnering with community organizations, advocacy groups, and other institutions that serve the Black/African American community.

Learn more →

A collaborative study with Johns Hopkins University School of Medicine and the National Institutes of Health, published in Blood Advances and involving 4 million participants, revealed that sickle cell trait (SCT) increases the risk of pulmonary embolism but not deep vein thrombosis. This suggests a unique clotting mechanism in people with SCT.

Learn more →

By improving the diversity of sarcoidosis research, this study aims to increase the likelihood that future treatments benefit historically underrepresented groups such as people with African ancestry. This initiative was a partnership with the Foundation for Sarcoidosis Research — the leading international organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients — and the Bernie Mac Foundation.

We expanded the number of genetic variants in our BRCA1/BRCA2 (Selected Variants) Genetic Health Risk report from 3 to 44 variants. This update improved the report for communities traditionally underserved by genetic testing. These 44 variants account for 30-40% of cancer-related BRCA1/BRCA2 variants in African Americans. We have collaborated with AfroPink® to increase awareness and access to our updated report.

Learn more →

This initiative aims to develop a genetic report that could help Black and African Americans learn more about their chances of developing colorectal cancer. We have worked with the Colorectal Cancer Alliance to help advance colorectal cancer research and raise awareness about this important health condition that disproportionately impacts the Black/African American community.

Learn more →

Scientific Leaders

23andMe has the largest cohort of people with African ancestry who have consented to participate in genetic research in the world, and we prioritize diversity through efforts like the African Genetics Project, the Global Genetics Project, and more. That focus on diversity has unlocked key discoveries through research.

Publications

2014

The genetic ancestry of African Americans, Latinos, and European Americans across the United States

Study significance: This study was pivotal in enhancing understanding of the genetic makeup of major ethnic groups in the United States, revealing the ongoing influence of historical and social factors on genetic diversity.

Published in: The American Journal of Human Genetics

2020

Genetic Consequences of the Transatlantic Slave Trade in the Americas

Study significance: This study represents the most detailed genetic analysis of the genetic impact of the transatlantic slave trade on populations across the Americas. It used data from over 50,000 individuals from the 23andMe database, representing African, European, and Indigenous American ancestries, to trace the genetic legacy of the forced migration of millions of Africans to the Americas.

Published in: The American Journal of Human Genetics

2023

The genetic legacy of African Americans from Catoctin Furnace

Study significance: This study demonstrates that when studied responsibly with input from stakeholders, long-buried DNA can be used to uncover obfuscated or forgotten histories of marginalized individuals.

Published in: Science

2023

A new method for multi-ancestry polygenic prediction improves performance across diverse populations

Study significance: Enables better risk-prediction models for individuals of non-European ancestry.

Published in: Nature Genetics

2024

Ancestry-Independent Risk of Venous Thromboembolism in Individuals with Sickle Cell Trait vs. Factor V Leiden

Study significance: This is the largest study ever conducted on sickle cell.

Published in: Blood Advances

Frequently Asked Questions

Have questions about our DNA test for people with African ancestry? Find answers to common questions about our testing process, privacy protections, and what makes 23andMe unique.

We compare your DNA to reference populations representing diverse African communities. Our database includes samples from people who trace their ancestry to specific regions and ethnic groups across Africa. We use advanced algorithms to identify which groups you share DNA with and provide matches with statistical confidence.

Yes. All 23andMe health services include Carrier Status reports for Sickle Cell Anemia and for Beta Thalassemia and Related Hemoglobinopathies (blood disorders). Knowing your carrier status can help you make informed decisions about family planning and understand your risk of passing the condition to your children.

Your privacy is our top priority. We employ software, hardware, and physical security measures to protect your data and exceed industry standards with 3 ISO certifications. You control whether your data is used for research, and we never sell your information without your explicit consent. You can download or delete your data at any time.

Yes. You can download your results and share them with your healthcare provider. We recommend discussing your results with a healthcare professional, especially if you have an "increased risk" or "variant detected" result.

Once your sample arrives at our lab, you can typically expect your results in 3-5 weeks. You'll receive an email notification when your reports are ready to view in your private 23andMe account.

23andMe genetic testing is generally not covered by insurance as it is a direct-to-consumer service. However, some employers offer discounts or reimbursement programs. You may also be able to use HSA/FSA funds depending on your plan. Check with your insurance provider for specific coverage details.

Find the service that is right for you

Ancestry Service

23andMe+ Premium Service

23andMe+ Total Health

Ancestry Reports and Features
Ancestry Reports

Includes Ancestry Composition, Maternal & Paternal Haplogroups, Neanderthal Ancestry. With 12 broad African reference populations, 260+ African ethnic groups, and more than 200 African American genetic groups.

DNA Relative Finder (opt in)

Find and connect with relatives in the 23andMe database who share DNA with you.

Automatic Family Tree Builder

Start a family tree automatically based on your DNA.

Enhanced ancestry features

Get advanced filtering for DNA Relative Finder and access up to 5000 DNA relatives.

Historical MatchesSM

Uncover your historical and ancient relatives, linking you to the past. Including historical and ancient individuals from West Africa, Southern Africa, and East Africa, as well as individuals of African descent who were enslaved at Catoctin Iron Furnace in Maryland.

Health Reports and Features
Health Predisposition Reports**

Including: BRCA1/BRCA2 (Selected Variants), Late-Onset Alzheimer's Disease, Type 2 Diabetes (Powered by 23andMe Research)

40+

Including some conditions that disproportionately impact Black and African American communities

40+

Including some conditions that disproportionately impact Black and African American communities

Carrier Status Reports**

Including conditions that disproportionately impact Black and African American communities, such as Sickle Cell Anemia and other blood disorders (hemoglobinopathies).

Wellness Reports

Including: Deep Sleep, Lactose Intolerance, Genetic Weight

10+10+
Pharmacogenetics reports***

Discover how your DNA may impact how your body processes certain medications.

Exome Sequencing ReportsΔ

Advanced DNA sequencing that looks at all the protein-coding regions of the genome.

Blood Testing

Eligible participants may order in-person blood testing initiated by a clinician.

Add-on purchaseAdd-on purchase 2x/yr included
Other
Trait Reports

30+ traits including: Sweet vs. Salty, Unibrow

Shop AncestryShop PremiumShop Total Health